Skip to main content
Clinical Trials/NCT04718298
NCT04718298
Completed
Not Applicable

Laparoscopic Fixation Free Obliteration of Inguinal Hernia Defect With the 3D Dynamic Responsive Implant ProFlor-E - Feasibility Study

University of Cagliari1 site in 1 country50 target enrollmentJune 1, 2019
ConditionsInguinal Hernia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Inguinal Hernia
Sponsor
University of Cagliari
Enrollment
50
Locations
1
Primary Endpoint
Feasibility of inguinal hernia defect obliteration with ProFlor
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This feasibility study highlights the features of the 3D dynamic responsive prosthesis ProFlor-E® for fixation free obliteration of inguinal hernia defect

Detailed Description

The 3D dynamic-responsive prosthesis for inguinal hernia repair ProFlor-E® recently introduced to the market has been laparoscopically employed for the repair of one recurrent inguinal hernia previously managed with anterior open approach. The scope of this feasibility study is to demonstrate that the positive effects of the 3D implant already proven in open inguinal hernia repair are also effective or even superior for the laparoscopic of recurrent/bilateral inguinal hernias compared to conventional treatment concept.

Registry
clinicaltrials.gov
Start Date
June 1, 2019
End Date
June 1, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Sequential
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Giuseppe Amato

Consultant Professor

University of Cagliari

Eligibility Criteria

Inclusion Criteria

  • patients with recurrent inguinal hernia already repaired with open approach or suffering by bilateral inguinal hernias

Exclusion Criteria

  • ASA \>4 patients

Outcomes

Primary Outcomes

Feasibility of inguinal hernia defect obliteration with ProFlor

Time Frame: intraoperative

Effectiveness of the laparoscopic procedure for inguinal hernia repair with ProFlor

Secondary Outcomes

  • Postoperative pain(from early stage until 18 months postop)

Study Sites (1)

Loading locations...

Similar Trials